{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:26:26Z","timestamp":1760264786416},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1996,4,1]],"date-time":"1996-04-01T00:00:00Z","timestamp":828316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1996,4]]},"DOI":"10.1007\/bf00873698","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T02:08:29Z","timestamp":1104113309000},"page":"S23-S26","source":"Crossref","is-referenced-by-count":19,"title":["Safety profile of copolymer 1: Analysis of cumulative experience in the United States and Israel"],"prefix":"10.1007","volume":"243","author":[{"given":"Amos D.","family":"Korczyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puiu","family":"Nisipeanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00873698_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0022-510X(77)90220-9","volume":"31","author":"O Abramsky","year":"1977","unstructured":"Abramsky O, Teitelbaum D, Arnon R (1977) Effect of a synthetic polypeptide (Cop-1) on patients with multiple sclerosis and acute disseminated encephalomyelitis: preliminary reports. J Neurol Sci 31:433\u2013438","journal-title":"J Neurol Sci"},{"key":"BF00873698_CR2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM198708133170703","volume":"317","author":"MB Bornstein","year":"1987","unstructured":"Bornstein MB, Miller A, Slagle S, et al (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408\u2013414","journal-title":"N Engl J Med"},{"key":"BF00873698_CR3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.41.4.533","volume":"41","author":"MB Bornstein","year":"1991","unstructured":"Bornstein MB, Miller A, Slagle S, et al (1991) A placebo-controlled, doubleblind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533\u2013539","journal-title":"Neurology"},{"key":"BF00873698_CR4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jama.1994.03520180017006","volume":"272","author":"P Cotton","year":"1994","unstructured":"Cotton P (1994) Options for multiple sclerosis. JAMA 272:1393","journal-title":"JAMA"},{"key":"BF00873698_CR5","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"KP Johnson","year":"1995","unstructured":"Johnson KP, Brooks BR, Cohen JA, et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, doubleblind, placebo-controlled trial. Neurology 45:1268\u20131276","journal-title":"Neurology"},{"issue":"Suppl 2","key":"BF00873698_CR6","first-page":"A358","volume":"44","author":"D Teitelbaum","year":"1994","unstructured":"Teitelbaum D, Meiner Z, Brenner T, et al (1994) Immunological parameters in a multicenter clinical trial of Cop-1 in multiple sclerosis (MS): a 2-year follow-up. Neurology 44 [Suppl 2]:A358-A359","journal-title":"Neurology"},{"key":"BF00873698_CR7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","volume":"43","author":"The IFNB Multiple Sclerosis Study Group","year":"1993","unstructured":"The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655\u2013661","journal-title":"Neurology"},{"key":"BF00873698_CR8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.45.7.1277","volume":"45","author":"The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS\/MRI Analysis Group","year":"1995","unstructured":"The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS\/MRI Analysis Group (1995) Interferon beta-1b in the treat ment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45:1277\u20131285","journal-title":"Neurology"},{"key":"BF00873698_CR9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0733-8619(18)30066-5","volume":"13","author":"HL Weiner","year":"1995","unstructured":"Weiner HL, Hohol MJ, Khoury SJ, et al (1995) Therapy for multiple sclerosis. Neurol Clin 13:173\u2013196","journal-title":"Neurol Clin"},{"key":"BF00873698_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.410370105","volume":"37","author":"B Weinstock-Guttman","year":"1995","unstructured":"Weinstock-Guttman B, Ransohoff RM, Kinkel RP, et al (1995) The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 37:7\u201315","journal-title":"Ann Neurol"},{"key":"BF00873698_CR11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.45.7.1245","volume":"45","author":"JS Wolinsky","year":"1995","unstructured":"Wolinsky JS (1995) Copolymer 1: a most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability. Neurology 45:1245\u20131247","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873698.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00873698\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:26:55Z","timestamp":1556306815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00873698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":11,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["BF00873698"],"URL":"https:\/\/doi.org\/10.1007\/bf00873698","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}